Gonadal Disorders clinical trials
The registry lists 25 studies for Gonadal Disorders across 9 countries. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-08-04. Counting its 31 narrower conditions too, such as Ovarian Neoplasms: 6,121 studies, 1,320 open.
Get an email when these change. Save the Gonadal Disorders studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
TesoRx Pharma, LLC (3) · VA Office of Research and Development (2) · KU Leuven (2) · University of Colorado, Denver (2) · Xiaoxiang Chen (1) · National Cancer Institute (NCI) (1) · Royan Institute (1) · University of Roma La Sapienza (1)
What is being tested here
Drugs under test in Gonadal Disorders studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
- Nov 2026Breaking Silence Through Story: A Narrative Medicine Intervention for Parents of Children With Urogenital Conditions · Sarah Schlegel
- Apr 2027Fertility Enhancement Through Regenerative Treatment in Ovaries and Testes · Jumeirah American Clinic
Who these studies take
Of the 3 Gonadal Disorders studies recruiting now, 2 (67%) set no upper age limit and 1 (33%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 1 (33%) for men only; 1 (33%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 1 (33%) | 2 (67%) |
| 30 | 2 (67%) | 3 (100%) |
| 40 | 2 (67%) | 3 (100%) |
| 50 | 2 (67%) | 3 (100%) |
| 65 | 1 (33%) | 2 (67%) |
| 75 | 1 (33%) | 2 (67%) |
| 85 | 1 (33%) | 2 (67%) |
Across all 25 studies, recruiting or not: 36% stop at 75 or younger and 24% at 65; 16% take children; 32% are for women only and 44% for men only; 12% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 25 of 25. search them.
- Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI TrialNot yet recruitingNCT07742553Phase 2/31 country
- Breaking Silence Through Story: A Narrative Medicine Intervention for Parents of Children With Urogenital ConditionsRecruitingNCT06989593Not applicable1 country
- Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord InjuryRecruitingNCT04460872Phase 21 country
- Fertility Enhancement Through Regenerative Treatment in Ovaries and TestesRecruitingNCT068413281 country
- A Novel Ovarian Reserve Monitoring Algorithm for Patients at Risk of Ovarian Injury From Gonadotoxic TherapyWithdrawnNCT05048654
- Testosterone Plus Finasteride Treatment After Spinal Cord InjuryTerminatedNCT02248701Phase 21 country
- PRecisiOn MEdicine to Target Frailty of Endocrine-metabolic OriginStatus unknownNCT048566831 country
- Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial CancerCompletedNCT03562897Phase 21 country
- A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone GelStatus unknownNCT04976595Phase 41 country
- The Health Influences of Puberty (HIP) StudyCompletedNCT01775813Phase 41 country
- Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian CancerStatus unknownNCT04556071Phase 21 country
- Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With GeneticsCompletedNCT003414581 country
- Value of MRI in the Characterization of Ovarian Masses Unable to Classify With Ultrasound Using the International Ovarian Tumor Analysis (IOTA) Simple RulesStatus unknownNCT02836275Not applicable1 country
- Prospective Validation and Comparison of Different Ultrasound Methods for Discrimination Between Benign and Malignant Ovarian/Tubal Masses Prior to SurgeryStatus unknownNCT028478321 country
- A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal MalesTerminatedNCT03335254Phase 1/21 country
- Avelumab in Refractory Testicular Germ Cell Cancer.CompletedNCT03403777Phase 21 country
- Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or HypogonadismCompletedNCT02081300Phase 3
- Long-term Outcome of GnRH Analogues Treatment of Children With Idiopathic Central Precocious PubertyStatus unknownNCT02790112Not applicable1 country
- Oral Testosterone for the Treatment of Hypogonadism in MalesCompletedNCT02222558Phase 21 country
- Oral Testosterone for the Treatment of HypogonadismCompletedNCT01717768Phase 21 country
- Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal HyperplasiaWithdrawnNCT02349503Phase 11 country
- Investigating the Regulation of Reproductive Hormones in Adult MenCompletedNCT00392457Not applicable1 country
- A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)CompletedNCT00749502Phase 1
- Comparison of Micro-dose Human Chorionic Gonadotropin (hCG) With Human Menopausal Gonadotropin (HMG) in Polycystic Ovary SyndromeCompletedNCT00947713Phase 1/21 country
- The Effect of Testosterone on Mood and Quality of LifeCompletedNCT00202462Not applicable